Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00427_DB00933_nanopub.RANsLdC5Z3mEUSo8_dD1HNIFcvSOh_WzcsJ_y1ZQ9FRwg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00427_DB00933 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00427_DB00933 label "DDI between Triprolidine and Mesoridazine - The antihistamine, Triprolidine, may increase the arrhythmogenic effect of the phenothiazine, Mesoridazine. Monitor for symptoms of ventricular arrhythmias. Additive anticholinergic and CNS depressant effects may also occur. Monitor for enhanced anticholinergic and CNS depressant effects. [drugbank_resource:DB00427_DB00933]" assertion.
- drugbank_resource:DB00427_DB00933 identifier "drugbank_resource:DB00427_DB00933" assertion.
- drugbank_resource:DB00427_DB00933 title "DDI between Triprolidine and Mesoridazine - The antihistamine, Triprolidine, may increase the arrhythmogenic effect of the phenothiazine, Mesoridazine. Monitor for symptoms of ventricular arrhythmias. Additive anticholinergic and CNS depressant effects may also occur. Monitor for enhanced anticholinergic and CNS depressant effects." assertion.
- drugbank:DB00427 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00427_DB00933 assertion.
- drugbank:DB00933 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00427_DB00933 assertion.